The reproducibility of adenosine monophosphate bronchial challenges in mild, steroid-naive asthmatics

British Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2008, Pages 261-265

  Singh, Dave ^a   Fairwood, Jennifer ^a   Murdoch, Robert ^b   Weeks, Amanda ^b   Russell, Paul ^b   Roy, Kay ^a   Langley, Steve ^a   Woodcock, Ashley ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adenosine; Asthma; Bronchial challenge; Reproducibility

Indexed keywords

ADENOSINE PHOSPHATE; STEROID;

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; OPEN STUDY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; REPRODUCIBILITY; SIDE EFFECT; TACHYPHYLAXIS; TREATMENT RESPONSE;

EID: 47249121722     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03186.x     Document Type: Article

References (11)

1. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lötvall J, Magnussen H, Polosa R, Postma DS, Riedler J ERS Task Force. Indirect airway challenges. Eur Respir J 2003 21 : 1050 68.
2. Van Schoor J, Pauwels R, Joos G. Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 2005 35 : 250 61.
3. Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction. Eur Respir J 2004 23 : 559 64.
4. Holgate ST, Arshad H, Stryszak P, Harrison JE. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma. J Allergy Clin Immunol 2000 105 : 906 11.
5. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor BJ. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol 2002 110 : 603 6.
6. Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, Barnes PJ, O'Connor BJ. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'- monophosphate in asthmatic patients. Am J Respir Crit Care Med 1999 160 : 237 43.
7. Phillips GD, Bagga PK, Djukanovic R, Holgate ST. The influence of refractoriness to adenosine 5'-monophosphate on allergen-provoked bronchoconstriction in asthma. Am Rev Respir Dis 1989 140 : 321 6.
8. Daxun Z, Rafferty P, Richards R, Summerell S, Holgate ST. Airway refractoriness to adenosine 5'-monophosphate after repeated inhalation. J Allergy Clin Immunol 1989 83 : 152 8.
9. Crimi N, Palermo F, Oliveri R, Polosa R, Vancheri C, Palermo B, Mistretta A. Tachyphylaxis to repeated challenges with inhaled adenosine in asthmatic subjects. Ann Allergy 1990 65 : 134 8.
10. Sims EJ, Jackson CM, Lipworth BJ. Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype. Br J Clin Pharmacol 2003 56 : 104 11.
11. Oosterhoff Y, Koeter GH, De Monchy JG, Postma DS. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects. Am Rev Respir Dis 1993 147 : 512 7.